// App-Quantinova.ai

: Multiomic Analysis of CD38 Expression Levels in 209 Untreated and Daratumumab-Resistant Patients

Researchers

Presenter

  • Max Johannes Steinhardt

Principal Investigators

  • Umair Munawar

  • Larissa Haertle

  • Seungbin Han

  • Cornelia Vogt

  • Silvia Nerreter

  • Eva Teufel

  • Julia Mersi

  • Max Bittrich

  • Sophia Danhof

  • Marietta Truger

  • Thomas Haaf

  • Santiago Barrio

  • Xiang Zhou

  • Joaquin Martinez-Lopez

  • Claudia Haferlach

  • Michael Hudecek

  • Hermann Einsele

  • Leo Rasche

  • Markus Sauer

  • K. Martin Kortuem

Medical Centers

  • Department of Internal Medicine II, University Hospital Wuerzburg, WüRzburg, Germany

  • HO-CNIO Hematological Malignancies Group, Clinical Research Unit. CNIO, Madrid, Spain

  • Department of Internal Medicine II, Department of Internal Medicine II, University Hospital WüRzburg, W, WüRzburg, Germany

  • Institute of Human Genetics, Julius Maximilians University, Wuerzburg, Germany

  • Biotechnology & Biophysics Biocenter, University of Wuerzburg, Wuerzburg, Germany

  • MLL Munich Leukemia Laboratory, Inning am Ammersee, Germany

Locations

  • Germany

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Peripheral blood mononuclear cell

  • Histone-lysine N-methyltransferase 2A

  • DNA methyltransferase 1

  • DNA methylation

Drug/Treatment

  • Tretinoin

  • Panobinostat

  • daratumumab Intravenous

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved